Product Description: Ombitasvir is a potent inhibitor of the hepatitis C virus protein NS5A, with EC50s of 0.82 to 19.3 pM against HCV genotypes 1 to 5, and 366 pM against genotype 6a.
Applications: COVID-19-anti-virus
Formula: C50H67N7O8
References: [1]Krishnan P, et al. In vitro and in vivo antiviral activity and resistance profile of ombitasvir, an inhibitor of hepatitis C virus NS5A. Antimicrob Agents Chemother. 2015 Feb;59(2):979-87/[2]DeGoey DA, et al. Discovery of ABT-267, a pan-genotypic inhibitor of HCV NS5A. J Med Chem. 2014 Mar 13;57(5):2047-57
CAS Number: 1258226-87-7
Molecular Weight: 894.11
Compound Purity: 99.79
Research Area: Infection
Solubility: DMSO : ≥ 33 mg/mL
Target: HCV